The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The Therapeutic Mode of Action of 4-Aminopyridine in Cerebellar Ataxia
Open accessAbstract
Episodic ataxia type 2 (EA2) is a hereditary cerebellar ataxia associated with mutations in the P/Q-type voltage-gated calcium (Ca 2+) channels. Therapeutic approaches for treatment of EA2 are very limited. Presently, the potassium (K+) channel blocker 4-aminopyridine (4-AP) constitutes the most promising treatment, although its mechanism of action is not understood. Here we show that, in contrast to what is commonly believed, therapeutic concentrations of 4-AP do not increase the inhibitory drive of cerebellar Purkinje cells. Instead, 4-AP restores the severely diminished precision of pacemaking in Purkinje cells of EA2 mutant mice by prolonging the action potential and increasing the action potential afterhyperpolarization. Consistent with this mode of action, the therapeutic efficacy of 4-AP was comparable, and not additive, to chlorzoxazone, an activator of Ca 2+-dependent K+channels that also restores the precision of Purkinje cell pacemaking. The likely target of 4-AP at the concentrations used are the K v 1 family of K+channels, possibly the K v 1.5 subtype. Because at higher concentrations 4-AP blocks a large array of K+channels and is a proconvulsant, use of selective K v 1 channel blockers is likely to be a safer substitute for treatment of cerebellar ataxia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Diversity of K+ Channels
COETZEE, W. A., AMARILLO, Y., CHIU, J., CHOW, A., LAU, D., McCORMACK, T., MORENA, H., NADAL, M. S., OZAITA, A., POUNTNEY, D., et al. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb11293.x · Cited by 1,095
Behavioral phenotyping strategies for mutant mice
Crawley, J. N. (2008) · Neuron · doi:10.1016/j.neuron.2008.03.001 · Cited by 439
Barclay, J., Balaguero, N., Mione, M., Ackerman, S. L., Letts, V. A., Brodbeck, J., Canti, C., Meir, A., Page, K. M., Kusumi, K., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-16-06095.2001 · Cited by 326 · cited 2×
“This larger Ca2 influx is likely to compensate, in part, for the reduced P/Q-type Ca2 current density associated with EA2 mutations (Fletcher et al., 1996; Dove et al., 1998; Barclay et al., 2001).”
Background
Cited by
Cerebellum and Ocular Motor Control
Kheradmand, A., & Zee, D. S. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00053 · Cited by 269
Metadata
- Authors
- Alviña, K., & Khodakhah, K.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2010-05-26
- Volume
- 30
- Issue
- 21
- Pages
- 7258-7268
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2114925267
- Cited by
- 185
- References
- 3
- FWCI
- 6.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Therapeutic Mode of Action of 4-Aminopyridine in Cerebellar Ataxia. https://app.cochat.ai/papers/10.1523/jneurosci.3582-09.2010
- The paper
- Alviña, K., & Khodakhah, K. (2010). The Therapeutic Mode of Action of 4-Aminopyridine in Cerebellar Ataxia. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.3582-09.2010
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.